Innovative Medtech (IMTH) Stock Statistics & Valuation Metrics
Total Valuation
Innovative Medtech has a market cap or net worth of $105.98K. The enterprise value is $725.35B.
- Market Cap
- $105.98K
- Enterprise Value
- $725.35B
Share Statistics
Innovative Medtech has 70,652,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 70,652,810
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Innovative Medtech’s return on equity (ROE) is -1.20 and return on invested capital (ROIC) is 675.78%.
- Return on Equity (ROE)
- -1.20
- Return on Assets (ROA)
- 5.07
- Return on Invested Capital (ROIC)
- 675.78%
- Return on Capital Employed (ROCE)
- 2.59
- Revenue Per Employee
- 0
- Profits Per Employee
- 1.27M
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Innovative Medtech is 0.05. Innovative Medtech’s PEG ratio is 0.00.
- PE Ratio
- 0.05
- PS Ratio
- 0.00
- PB Ratio
- -0.06
- Price to FCF
- 0.03
- Price to Operating Cash Flow
- 0.02
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Innovative Medtech had revenue of 0 and earned 1.27M in profits. Earnings per share was 0.03.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -2.73M
- Pretax Income
- 1.27M
- Net Income
- 1.27M
- EBITDA
- -2.02M
- Earnings Per Share (EPS)
- 0.03
Cash Flow
In the last 12 months, operating cash flow was 2.85M and capital expenditures 0, giving a free cash flow of 2.85M billion.
- Operating Cash Flow
- 2.85M
- Free Cash Flow
- 2.85M
- Free Cash Flow per Share
- 0.08
Dividends & Yields
Innovative Medtech pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2905.94%
- Earnings Yield
- 2068.80%
Stock Price Statistics
- Beta
- -0.96
- 52-Week Price Change
- -69.57%
- 50-Day Moving Average
- 0.07
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- 44.20
- Average Volume (3m)
- ―
Financial Position
Innovative Medtech as a current ratio of 0.02, with Debt / Equity ratio of -61.65%
- Current Ratio
- 0.02
- Quick Ratio
- 0.02
- Debt to Market Cap
- 0.24
- Net Debt to EBITDA
- -0.32
- Interest Coverage Ratio
- 50.25
Taxes
In the past 12 months, Innovative Medtech has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Innovative Medtech EV to EBITDA ratio is -0.37, with an EV/FCF ratio of 0.24.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.37
- EV to Free Cash Flow
- 0.24
- EV to Operating Cash Flow
- 0.24
Balance Sheet
Innovative Medtech has $13.62K in cash and marketable securities with $649.21K in debt, giving a net cash position of -$635.59K billion.
- Cash & Marketable Securities
- $13.62K
- Total Debt
- $649.21K
- Net Cash
- -$635.59K
- Net Cash Per Share
- -$0.01
- Tangible Book Value Per Share
- -$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Innovative Medtech is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
